Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Leases (2019 - 2026)

Collegium Pharmaceutical has reported Current Leases over the past 7 years, most recently at $1.4 million for Q4 2025.

  • For Q4 2025, Current Leases rose 10.7% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 10.7%, while the annual FY2025 figure was $1.4 million, 10.7% up from the prior year.
  • Current Leases for Q4 2025 was $1.4 million at Collegium Pharmaceutical, up from $1.4 million in the prior quarter.
  • Over five years, Current Leases peaked at $1.4 million in Q4 2025 and troughed at $750000.0 in Q1 2021.
  • A 5-year average of $1.1 million and a median of $1.1 million in 2022 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: soared 57.07% in 2022 and later fell 19.82% in 2023.
  • Year by year, Current Leases stood at $814000.0 in 2021, then soared by 36.61% to $1.1 million in 2022, then decreased by 11.15% to $988000.0 in 2023, then grew by 28.64% to $1.3 million in 2024, then rose by 10.7% to $1.4 million in 2025.
  • Business Quant data shows Current Leases for COLL at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.3 million in Q2 2025.